(Q35895832)

11 August 2017

Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

11 August 2017

1 reference

1 reference

1 reference

Munechika Enjoji

1

1 reference

11 August 2017

Kenichiro Yasutake

series ordinal

2

1 reference

11 August 2017

Motoyuki Kohjima

series ordinal

3

1 reference

11 August 2017

Makoto Nakamuta

series ordinal

4

1 reference

11 August 2017

language of work or name

1 reference

5 April 2012

1 reference

International Journal of Hepatology

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

925807

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Histopathology of nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Role of cannabinoids in the development of fatty liver (steatosis)

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Recent advances in nonalcoholic fatty liver disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Current and emerging therapies in nonalcoholic fatty liver disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Cholesterol and sphingolipids in alcohol-induced liver injury

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Alcohol-induced steatosis in liver cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Liver X receptors as integrators of metabolic and inflammatory signaling

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Protein sensors for membrane sterols

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

The role of AMP-activated protein kinase in the action of ethanol in the liver

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Molecular mediators of hepatic steatosis and liver injury

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Sterol absorption by the small intestine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Nonalcoholic fatty liver disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Liver fat and lipid oxidation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Dietary composition and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F925807

Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328950

A physiological method for estimation of hepatic secretion of biliary lipids in man

24 September 2018

1 reference

12 December 2020

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis

1 reference

12 December 2020

Dietary habits and nutrient intake in non-alcoholic steatohepatitis

1 reference

12 December 2020

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/925807

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22550592

1 reference